Stroke in relation to use of raloxifene and other drugs against osteoporosis

Author： Vestergaard P. Schwartz K. Pinholt E. Rejnmark L. Mosekilde L.

ISSN： 0937-941X

Source： Osteoporosis International, Vol.22, Iss.4, 2011-04, pp. : 1037-1045

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-term raloxifene for postmenopausal osteoporosis

By Recker Robert R. Mitlak Bruce H. Ni Xiao Krege John H.

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1755-1761

Informa Healthcare

Access to resources Recommend Favorite

Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture

By Ferrari S.

Osteoporosis International, Vol. 21, Iss. 2, 2010-06 ,pp. : 437-442

Springer Publishing Company

Access to resources Recommend Favorite

The use of antithrombotic drugs for primary and secondary prevention of ischaemic stroke

Reviews in Clinical Gerontology, Vol. 6, Iss. 4, 1996-11 ,pp. : 315-323

Cambridge University Press

Access to resources Recommend Favorite

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women

By Ringe J. D. Christodoulakos G. E. Mellström D. Petto H. Nickelsen T. Marín F. Pavo I.

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2677-2687

Informa Healthcare

Access to resources Recommend Favorite

Limited Fine Hand Use after Stroke and its Association with other Disabilities

By Welmer Anna-Karin Holmqvist Lotta Widén Sommerfeld Disa K.

Journal of Rehabilitation Medicine, Vol. 40, Iss. 8, 2008-09 ,pp. : 603-608

Medical Journals Limited

Access to resources Recommend Favorite